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3Abstract 
Objective: 22q11.2 Deletion Syndrome (22q11.2DS) is associated with increased risk 
for schizophrenia in adulthood while ADHD is the most prevalent diagnosis in childhood. 
Inattention symptoms are pronounced in 22q11.2DS and given that attentional 
impairment is a core feature of schizophrenia, inattention symptoms may reflect 
underlying ADHD, psychosis, or both. We investigate whether inattention is associated 
with psychosis in 22q11.2DS and in other groups at risk for psychosis but without the 
deletion (ND) (idiopathic clinical risk and first degree family members of individuals with 
schizophrenia). 
Methods: 137 individuals with 22q11.2DS (mean age: 14.0), 84 ND individuals with 
subthreshold psychosis (mean age: 16.9) and 31 ND individuals with family history of 
psychosis (mean age: 17.0) were included in the study. Psychopathology was assessed 
using research diagnostic assessments.   
Results: ADHD total symptoms were associated with overall levels of subthreshold 
psychosis symptoms in 22q11.2DS (β=0.8, p=0.04). Inattention symptoms were 
specifically associated with positive (β=0.5, p=0.004), negative (β=0.5, p=0.03), and 
disorganized (β=0.5, p<0.001) symptoms, while hyperactivity-impulsivity symptoms 
were associated with disorganized symptoms (β=0.5, p=0.04). The prevalence of ADHD 
inattention symptoms was higher in 22q11.2DS with subthreshold  psychosis compared 
to ND individuals with subthreshold psychosis (p<0.001), even when adjusting for 
cognitive impairment and overall psychopathology. The pattern was similar when 
comparing individuals with 22q11.2DS and ND individuals with family history of 
psychosis.  
4Conclusions: This is the first study to examine the associations between ADHD and 
psychosis in 22q11.2DS. Our findings support a potentially important role of ADHD 
inattention symptoms in psychosis in 22q11.2DS.
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Introduction 
22q11.2 Deletion Syndrome (22q11.2DS) is a chromosomal disorder caused by a 
microdeletion of ~40 genes. It has been associated with multiple physical 
manifestations, most related to disruptions of neural crest development1, 2. 22q11.2DS 
is also one of the strongest known genetic risk factors for schizophrenia, associated 
with about a 30% increased risk of developing this disorder in adulthood3. Children with 
22q11.2DS have been reported to be at risk for developing a range of psychiatric 
disorders, including autism, Oppositional Defiant Disorder (ODD) and anxiety disorders   
3-5. Attention Deficit Hyperactivity Disorder (ADHD) is the most prevalent childhood 
psychiatric disorder with reported rates estimated at 37%3 compared to 2-6% in the 
general population6. Studies comparing features of ADHD between 22q11.2DS and 
individuals without the deletion have indicated that inattention symptoms in 22q11.2DS 
are pronounced7, 8. Such symptoms include difficulties focusing and sustaining 
attention, difficulties with organizing tasks, easily forgetting and losing things, and may 
reflect attentional and working memory dysfunction9. 
Notably, inattention is a core symptom of both ADHD and schizophrenia10. Attentional 
impairment has been long recognized as a core characteristic of schizophrenia, where 
6clinically relevant symptoms of inattention are often present (e.g.11). Studies of 
childhood onset schizophrenia have indicated prevalent premorbid ADHD-like 
symptoms12-14. Increased rates of inattentive symptoms have also been reported in 
clinical15, 16 and non-clinical samples17, 18 of individuals with prodromal symptoms of 
psychosis, as well as in individuals at genetic risk due to family history19. These findings 
support that attentional impairments are evident early in the course of the illness and/or 
are associated with genetic liability to psychosis.  
In light of this evidence, it is possible that the high prevalence of inattention symptoms 
in 22q11.2DS may reflect additional emerging risk for psychosis or it could be that 
22q11.2DS increases risk for both ADHD and psychosis. Given that attentional 
impairment is also taken into account for the diagnosis of schizophrenia, it is important 
to disentangle this symptom overlap with ADHD as this can improve our understanding 
of risk for schizophrenia in 22q11.2DS. Moreover, if ADHD inattention symptoms are 
associated with genetic liability to psychosis, their earlier manifestation in relation to 
psychosis could indicate that they are on the pathway between genetic risk and 
schizophrenia in 22q11.2DS. This can have potentially important implications for 
prevention and treatment in 22q11.2DS as well as for future genetic studies. Although a 
previous study did not find evidence that ADHD is associated with development of 
psychosis20, the sample was small (n=28) and the study examined only diagnoses, 
rather than ADHD symptoms. The evidence is weak for a role of ADHD in psychosis in 
populations without the deletion. A longitudinal follow-up study on over 200 children with 
ADHD suggested an increased risk of schizophrenia in adulthood21, but other 
7longitudinal studies have not found such associations22-24. Our prior work examining 
comorbidity in 22q11.2DS found that among participants with 22q11.2DS and ADHD, 
64.1% also had psychosis spectrum disorders and 41% of 22q11.2DS participants with 
psychosis spectrum disorders had ADHD25, a finding that indicates a potential role for 
ADHD in the development of psychosis in 22q11.2DS. The current study with the same 
22q11.2DS participants extends these findings as the first to examine whether particular 
ADHD symptoms, are associated with subthreshold psychosis symptoms in individuals 
with 22q11.2DS. 
Another way to investigate whether the ADHD inattention symptoms are associated with 
genetic liability to psychosis in 22q11.2DS is to compare their prevalence with that of 
individuals without the deletion (ND) who are also at high risk of psychosis. Previous 
studies have examined either the prevalence of ADHD inattention symptoms in relation 
to ADHD hyperactivity-impulsivity symptoms within 22q11.2DS26, 27 or the prevalence of 
ADHD inattention symptoms when compared to ND ADHD samples7, 8. However, no 
study has directly compared the prevalence of ADHD symptoms in 22q11.2DS with 
other groups with increased risk for psychosis, including youths with subthreshold 
psychosis symptoms and first-degree relatives of individuals with psychosis. Examining 
the prevalence of ADHD symptoms in these groups can help understand how these 
symptoms relate to risk for psychosis in 22q11.2DS. If these ADHD symptoms, 
particularly inattentive, are associated with genetic liability for psychosis, then their 
prevalence should be analogous to the extent of risk for psychosis in populations at high 
risk for psychosis. Considering that risk for psychosis is higher in 22q11.2DS relative to 
8individuals with subthreshold psychosis28 and family history of psychosis29, then the 
prevalence of ADHD inattention symptoms would also be higher in individuals with 
22q11.2DS in comparison with the ND groups.   
The main goals of this study were: 1) examine whether ADHD symptoms are associated 
with subthreshold psychosis symptoms in individuals with 22q11.2DS. We hypothesized 
that ADHD symptoms, particularly ADHD inattention symptoms, would be associated 
with psychosis spectrum symptoms in individuals with 22q11.2DS; 2) compare the 
prevalence of ADHD symptoms between the following groups: a) individuals with 
22q11.2DS and subthreshold psychosis symptoms and ND individuals with 
subthreshold psychosis symptoms and b) individuals with 22q11.2DS and ND 
individuals with a family history of psychosis. We hypothesized that the frequency of 
ADHD inattention symptoms would be higher in individuals with 22q11.2DS in 
comparison with the ND groups. 
To address these aims we conducted one of the largest studies of individuals with 
22q11.2DS and we also evaluated ND groups who were assessed using the same 
detailed phenotypic assessments. 
9Method 
Samples 
Participants, with 22q11.2DS and ND, were selected from two ongoing prospective 
studies that used the same phenotypic assessments to enable direct comparisons.  
Both groups were recruited from medical clinics and community sources. Individuals 
with 22q11.2DS were selected based on the deletion whereas the ND group was 
selected from a larger pool that was community screened and then selected for 
longitudinal evaluation based on the presence or absence of subthreshold psychosis 
symptoms at baseline, as described previously4, 30-32. A total of 137 individuals with 
22q11.2DS were included in the study. A subset of 72 individuals with 22q11.2DS were 
classified as having significant subthreshold psychosis symptoms (see31), and they 
were compared with 84 ND individuals, also with subthreshold psychosis symptoms33. 
This comparison was made in order to compare two groups that are at clinical high risk 
for psychosis based on existing symptoms.   
The entire sample of 22q11.2DS was compared to 31 ND individuals with family history 
of psychosis, in a first-degree relative as assessed by an abbreviated version of the 
Family Interview for Genetics Studies34 using procedures described by Calkins et al33. 
This allows comparison of one genetic model for psychosis risk (22q11.2DS confers 
genetic risk for psychosis, whether or not psychosis symptoms are currently present) 
against another (individuals with family history of psychosis have genetic risk for 
psychosis regardless of whether they are currently symptomatic).  
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The Institutional Review Boards of the University of Pennsylvania and the Children’s 
Hospital of Philadelphia (CHOP) approved the study. Informed consent/assent was 
obtained from adult participants and from caretakers of younger participants with their 
assent. 
Measures 
A modified version of the Kiddie-Schedule for Affective Disorders and Schizophrenia for 
School-Age Children (K-SADS)35 was administered to obtain DSM-IV-TR diagnoses of 
ADHD for both 22q11.2DS and non-deleted samples. The K-SADS is a semi-structured 
interview that assesses categorical diagnoses as well as symptom counts of psychiatric 
disorders, including ADHD. We examined ADHD inattention, hyperactivity-impulsivity 
and total symptoms. Although ADHD symptoms were the focus of the study, we also 
examined the categorical DSM-IV-TR ADHD diagnosis.  
The Structured Interview for Prodromal Syndromes (SIPS)36 was used to obtain Scale 
of Prodromal Symptoms (SOPS) ratings of positive, negative, disorganized and general 
symptoms. Individuals were classified as “subthreshold psychosis” based on significant 
positive, negative and/or disorganized symptoms as previously described25, 31, 33. 
Specifically, “subthreshold psychosis” diagnoses were given if the individuals reported 
at least 1 positive symptom rated >=3 or at least 2 negative and/or disorganized 
symptoms rated >=3. Interviews were conducted by experienced and trained clinical 
assessors who were supervised by clinical investigators. SOPS symptom ratings and 
11
DSM-IV-TR diagnoses of psychotic disorders and ADHD were achieved via case 
conference consensus review by at least two doctoral level clinicians.  
Reading proficiency was estimated using the Wide Range Achievement Test -4 (WRAT-
4) Reading subtest, which assesses the ability to recognize and pronounce words, listed 
in order of increasing vocal complexity and difficulty37. We also obtained a composite 
measure of executive function from the Penn computerized Neurocognitive Battery38-40. 
It included the Penn Conditional Exclusion Test (PCET) and the Penn Letter N-back 
Test (NBACK). We did not formally assess IQ in our study. 
Data analysis 
Data analyses were conducted with Stata (version 13)41. Linear regressions within the 
22q11.2DS group examined the associations between ADHD scores and SOPS.  
Student’s t-tests or, in the case of non-normally distributed variables, Mann-Whitney U 
tests, were applied to compare demographic and clinical variables as well as symptom 
counts. Chi-square tests were used to compare the rates of ADHD diagnosis between 
the groups. As a supplementary analysis, the Wilcoxon matched-pairs signed-rank test 
was used to examine whether the ADHD diagnosis and symptom counts were similar 
between the 22q11.2DS and individuals without a deletion with family history of 
psychosis after matching for sex and age. To account for the potential confounding 
effects of age, reading proficiency, executive functioning and total SOPS on the ADHD 
symptom scores, the former were regressed out of the ADHD symptom scores before 
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performing analyses. Specifically, using regression, each ADHD symptom score was 
predicted using age, age-squared, age-cubed, WRAT 4, composite executive score and 
total SOPS. The residuals of this analysis therefore reflected ADHD symptomatology 
above or below what would be expected given one’s age, reading proficiency, executive 
functioning and total SOPS. We excluded symptom D3 (significant attentional 
impairments) from SOPS total, to avoid over-adjusting. Analyses were repeated to only 
include Caucasians in order to exclude potential confounding due to race differences.  
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Results
Aim 1. Associations between ADHD symptoms, psychosis spectrum symptoms and 
psychosis in 22q11.2DS (Table 1)
ADHD inattention symptoms were associated with positive symptoms (Cohen’s f2=0.07, 
p=0.004), negative symptoms (Cohen’s f2=0.04, p=0.03), disorganized symptoms 
(Cohen’s f2=0.11, p<0.001), total SOPS symptoms (Cohen’s f2=0.06, p=0.01) and with 
subthreshold psychosis (Odds Ratio (OR)=1.18, p=0.004). There was no evidence for 
associations between ADHD inattention symptoms and general symptoms (Cohen’s 
f2=0.01, p=0.22), threshold diagnoses of schizophrenia (OR=1.5, p=0.18) or other 
psychotic disorders (OR=1.05, p=0.71).  
ADHD hyperactivity-impulsivity symptoms were associated with disorganized symptoms 
(Cohen’s f2=0.06, p=0.01) and with subthreshold psychosis classification (OR=1.21, 
p=0.01). There was no evidence for associations with positive symptoms (Cohen’s 
f2=0.00, p=0.64), negative symptoms (Cohen’s f2=0.00, p=0.78), general symptoms 
(Cohen’s f2=0.02, p=0.17), total SOPS symptoms (Cohen’s f2=0.01, p=0.24), 
schizophrenia (OR=1.1, p=0.66) or other psychotic disorders (OR=1.1, p=0.63). 
ADHD total symptoms were associated with disorganized symptoms (Cohen’s f2=0.10, 
p<0.001), total SOPS (Cohen’s f2=0.04, p=0.04) and subthreshold psychosis (OR=1.12, 
p=0.003) while there was weak evidence for association with positive symptoms 
(Cohen’s f2=0.02, p=0.09) but no evidence for association with negative symptoms 
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(Cohen’s f2=0.01, p=0.24), general symptoms (Cohen’s f2=0.02, p=0.18), schizophrenia 
(OR=1.12, p=0.31) or psychotic disorders (OR=1.00, p=0.98). 
Aim 2a. Comparisons of ADHD symptomatology between individuals with 22q11.2DS 
and subthreshold psychosis and ND individuals with subthreshold psychosis (Table 2)
The 22q11.2DS subthreshold psychosis sample was on average younger than the ND 
subthreshold psychosis sample (Cohen’s d=-0.88, p<0.001), while there were no sex 
differences (Cohen’s d=0.16, p=0.32). Although the estimated household income was 
higher in 22q11.2DS individuals (Cohen’s d=0.76, p<0.001) there were no differences at 
the maternal education level (Cohen’s d= 0.26, p=0.06) in relation to the ND sample 
with subthreshold psychosis. However, the 22q11.2DS subthreshold psychosis sample 
had lower WRAT4 scores (Cohen’s d=-1.89, p<0.001) and had lower performance on 
the composite executive function measure (Cohen’s d=-1.43, p<0.001). 22q11.2DS 
subthreshold psychosis sample reported less positive symptoms (Cohen’s d=-0.43, 
p=0.01), more negative (Cohen’s d=0.53, p=0.001), more disorganized (Cohen’s 
d=0.49, p=0.003), more general (Cohen’s d=0.82, p<0.001) and more total SOPS 
(Cohen’s d=0.50, p=0.003) in relation to ND individuals with subthreshold psychosis. 
22q11.2DS subthreshold psychosis sample exhibited more ADHD inattention symptoms 
(Cohen’s d=0.95, p<0.001), more ADHD hyperactivity-impulsivity symptoms (Cohen’s 
d=0.54, p=0.004) and more ADHD total symptoms (Cohen’s d=0.75, p<0.001) relative 
to the ND individuals with subthreshold psychosis. These differences remained for the 
ADHD inattention symptoms and the ADHD total symptoms but disappeared for the 
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ADHD hyperactivity-impulsivity symptoms when age, WRAT4, composite executive 
scores and total SOPS were taken into account.  
Supplementary analyses restricted to the Caucasian subsamples yielded similar results 
(Table S1).  
Aim 2b. Comparisons of ADHD symptomatology between individuals with 22q11.2DS 
and ND individuals with family history of psychosis (table 3)
The 22q11.2DS sample was on average younger than the ND sample with family 
history of psychosis (Cohen’s d=-0.72, p<0.001), while there were no sex differences 
(Cohen’s d=0.12, p=0.50). The estimated household income was higher in 22q11.2DS 
individuals (Cohen’s d=1.05, p<0.001) as was maternal education level (Cohen’s d=
0.71, p<0.001) in relation to the ND sample with family history. However, the 22q11.2DS 
sample had lower WRAT4 scores (Cohen’s d=-0.89, p=0.002) and performed worse on 
the composite executive function measure (Cohen’s d=-1.49, p<0.001). The 22q11.2DS 
sample exhibited fewer positive (Cohen’s d=-0.35, p=0.04), more negative (Cohen’s 
d=0.41, p=0.005) and more general symptoms (Cohen’s d=0.48, p=0.004) compared to 
ND individuals with family history of psychosis. No differences were found with regards 
to disorganized and total SOPS.  
The 22q11.2DS sample had more ADHD inattention symptoms (Cohen’s d=0.86, 
p<0.001), more ADHD hyperactivity–impulsivity symptoms (Cohen’s d=0.68, p<0.004) 
and more ADHD total symptoms (Cohen’s d=0.81, p<0.001). These differences 
remained for the ADHD inattention symptoms and the ADHD total symptoms but 
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disappeared for the ADHD hyperactivity-impulsivity symptoms when age, WRAT4, 
composite executive scores and SOPS were taken into account. The findings examining 
only the Caucasian subsamples and when matched for age and sex comparisons 
between individuals with 22q11.2DS and ND individuals with family history of psychosis 
were similar to the main analysis (Supplemental Tables S2 and S3). 
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Discussion  
This is the first study to examine the associations between ADHD symptoms and 
psychosis symptoms in 22q11.2DS. ADHD symptoms, including inattention and 
hyperactivity–impulsivity, were associated with overall subthreshold psychosis 
classification, while inattention symptoms were also associated with positive, negative, 
and disorganized symptoms. Hyperactivity-impulsivity symptoms were associated only 
with disorganized symptoms. The prevalence of ADHD inattention symptoms was 
higher in individuals with 22q11.2DS and subthreshold psychosis in relation to ND 
individuals with subthreshold psychosis even when adjusting for reading proficiency, 
overall executive function and SOPS, while there was only weak evidence for higher 
prevalence of ADHD hyperactivity-impulsivity symptoms. The pattern was similar when 
comparing individuals with 22q11.2DS with ND individuals with family history of 
psychosis.  
ADHD inattention symptoms and psychosis  
Our hypothesis that ADHD inattention symptoms would be associated with psychosis 
spectrum symptoms in individuals with 22q11.2DS was supported. While these 
symptoms were not associated with schizophrenia or psychotic disorders in 22q11.2DS, 
this may be due to low power given that schizophrenia and psychosis were present in 
only 3% and 5% of the sample, respectively.   
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Our findings accord with previous studies in the general population17, 18 and other 
clinical samples15, 16 that have suggested a role for ADHD in psychosis. Interestingly, 
the prevalence of the inattention symptoms was higher in individuals with 22q11.2DS 
when compared to individuals with family history of psychosis. Although family history of 
psychosis confers genetic risk for psychosis, the risk rates are much lower in relation to 
the rates reported in 22q11.2DS42, therefore, lower prevalence of inattention symptoms 
in this group when compared to 22q11.2DS could indicate that inattention symptoms 
are related to genetic risk for psychosis. Although genetic studies have not examined 
the shared genetic underpinnings of ADHD inattention symptoms and schizophrenia, 
there is evidence for shared genetic susceptibility between ADHD and schizophrenia 43
as well as for rare CNVs44 contributing to both. 
There are at least three possible explanations for the observed findings.  
First, inattentive symptoms might be on a common pathway leading from genetic risk to 
the development of inattentive symptoms and consequently to the development of 
ADHD and schizophrenia10.  
Second, it is possible that ADHD inattention symptoms in the context of, or preceding 
other subthreshold psychosis symptoms, are phenomenologically similar to ADHD-like 
behaviors but reflect a premorbid or prodromal form of schizophrenia risk rather than 
ADHD per se.  Cornblatt and colleagues (1994) suggested a model that can explain 
how attentional dysfunction can trigger psychosis45. According to this model, inattention 
problems can lead to defective processing of social cues that can result in deficient 
social skills that in turn can make social interactions particularly stressful. This could 
potentially lead to avoidance of interactions as a way to control symptoms. Conversely, 
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interactions could be sought that elicit stress and exacerbate developing symptoms. 
Finally, it is possible that the association between inattention symptoms and psychosis 
symptoms is the result of shared genetic variance and that this association results from 
pleiotropic genetic effects. Genetic and longitudinal studies are needed to improve our 
understanding of the potential mechanisms underlying risk for ADHD and 
schizophrenia.  
Importantly, the differences in rates of ADHD inattention symptoms between individuals 
with the 22q11DS and ND remained despite controlling for reading proficiency and 
executive function that have been associated with risk for ADHD46. Studies have 
indicated that ADHD symptoms might not be unique to ADHD and instead could be 
associated with other psychiatric problems47, 48. Our recent confirmatory analysis of 
psychopathology in 22q11.2DS49 indicated that, similar to populations without a 
deletion, psychopathology was divided into one ‘general psychopathology’ (p factor50) 
and four specific dimensions, including ADHD. It could therefore be that these ADHD 
symptoms indicate a more general vulnerability to psychopathology that is potentially 
over and above the cognitive deficits that underlie risk for ADHD in 22q11.2DS. Our 
findings however, could also indicate that the cognitive measures we used were not 
sensitive enough to capture the cognitive deficit that underlies these symptoms. 
Weak evidence for associations of ADHD hyperactivity-impulsivity symptoms 
with psychosis 
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Although ADHD hyperactivity-impulsivity symptoms were associated with subthreshold 
psychosis in 22q11.2DS, the comparisons of their prevalence between the 22q11.2DS 
and the ND at risk groups did not support a strong role of hyperactivity–impulsivity in 
psychosis in 22q11.2DS. This is in accordance with a previous birth-cohort study that 
did not find evidence of a link between psychotic symptoms and hyperactive 
symptoms17. One explanation could be the different role that dopaminergic function 
plays in schizophrenia and ADHD. Dopamine is one of the main neurotransmitters that 
is considered to be involved in the pathophysiology of both schizophrenia and ADHD51. 
Dopaminergic hypoactivity in the brain is the most likely cause of ADHD52 and is mostly 
related to impulsivity53, 54. Dopaminergic imbalance55,  which resembles dopaminergic 
hyperactivity56, 57, has been mostly related to the positive psychotic symptoms of 
schizophrenia. Thus, the absence of evidence for associations between ADHD 
hyperactivity-impulsivity and psychosis in our sample could be due to different biological 
mechanisms underlying these traits. Alternatively, we cannot exclude the possibility of 
Type II error in our findings. 
Finally, total symptoms were also associated with psychosis spectrum symptoms, a 
finding which accords with findings from a population based study that indicated a 
longitudinal association between ADHD combined subtype at age 7 and psychotic 
symptoms at age 1258. Interestingly, this study did not find longitudinal associations 
between the inattentive and hyperactive subtype of ADHD and later development of 
psychotic disorder.  
Theoretical and clinical implications 
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Our findings have potentially important theoretical and clinical implications. The cross-
sectional associations between ADHD inattention symptoms and psychosis spectrum 
symptoms indicate that a longitudinal study to examine these associations is warranted.  
If ADHD inattention symptoms are antecedents of psychosis spectrum symptoms in 
22q11.2DS, then assessing these readily observable symptoms may aid detection of 
those individuals with 22q11.2DS who are at particularly high-risk for psychosis. 
Similarly, our findings indicate that individuals with 22q11.2DS with psychosis 
symptoms might also have ADHD inattention symptoms that need to be addressed 
given that ADHD inattention symptoms can pose an additional impediment to the 
individuals’ emotional, social and occupational well-being59, 60. Our findings are also 
consistent with the NIMH Research Domain Criteria (RDoC) initiative as they indicate 
the importance of examining psychopathology not only in diagnostic categories but also 
dimensionally, as using the former might be missing individuals who are at risk but do 
not meet the diagnostic cut-offs60. Another potential clinical implication relates to the 
diagnosis and treatment of ADHD. Stimulants that are usually prescribed for ADHD 
have potentially opposing action in relation to antipsychotic medication taking into 
account the former act as dopamine agonists while the latter as dopamine 
antagonists61. If these ADHD inattention symptoms are also part of prodromal psychosis 
in 22q11.2DS, then future studies should examine the longitudinal effects of stimulant 
treatment as they might potentiate or alter the course of psychosis symptoms in 
someone who is vulnerable62, 63.  
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Moreover, if ADHD symptoms are antecedents of psychosis, studies should examine 
whether non-pharmacological treatments addressing ADHD symptoms in childhood can 
potentially reduce risk for later psychosis in addition to improving function. Further 
longitudinal and sufficiently powered studies using detailed phenotypic assessments are 
needed to replicate our findings. 
Strengths and limitations 
This is one of the largest studies of individuals with 22q11.2DS that also includes large 
samples of ND high-risk comparison groups. The additional strength of our study is that 
the phenotypic assessments were the same between the groups, allowing for 
comparisons. While 86% of the individuals with 22q11.2DS were Caucasian, which is in 
accordance with previous studies of this disorder3, only 68% of the ND individuals with 
subthreshold psychosis and 71% of the ND individuals with family history of psychosis 
were Caucasian. Our supplementary analyses restricted to Caucasians, though 
necessarily less powerful, yielded similar findings as the total sample. Moreover, there 
were socioeconomic differences between the samples, with the 22q11.2DS group 
having higher estimated household income and higher maternal education levels. 
However, these differences are more likely to have led to an underestimation in 
observed associations. Another limitation is the cross-sectional nature of the study that 
does not allow us to delineate whether these inattention symptoms are antecedents or 
correlates of psychotic phenomena. Additionally, although we adjusted for WRAT4, an 
approximation of IQ, and executive function, we did not adjust for IQ using IQ specific 
measures making it possible that some portion of the observed attention effects may be 
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associated with the comparatively lower IQ in participants with 22q11.2DS. Finally, 
because our sample with individuals with 22q11.2DS also included children who are 
less likely to be diagnosed with psychosis, our results may again underestimate the 
magnitude of the associations between inattention and psychosis symptoms.  
An important consideration when interpreting these findings is that, in the subthreshold 
psychosis comparisons between 22q11.2DS and ND individuals, significant attentional 
impairment (SOPS item D3) is one of the symptoms that can contribute to a 
subthreshold psychosis classification. This reflects the common symptom of inattention 
in both “prodromal” and ADHD diagnoses, but including this item in the diagnostic 
classification for subthreshold psychosis might have led to the selection of a sample 
with overall higher prevalence of inattention symptoms. Nonetheless, because this 
criterion was applied to both 22q11.2DS and ND groups, it cannot influence the 
comparisons of the prevalence of ADHD symptoms between the two groups.  
Moreover, we did not include individuals without a deletion and without a family history 
of psychosis because an unbiased sample without family history of psychosis was not 
available. All of our ND individuals were selected on the presence or absence 
of psychosis spectrum symptoms, and psychosis spectrum symptoms have been 
associated with positive family history of psychosis. However, presence of psychosis 
family history is not necessary for the subsequent development of psychotic disorders 
and therefore our ND samples might not be representative of the population of 
individuals with psychosis.   
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Conclusions 
We examined the associations between ADHD symptoms and subthreshold psychosis 
symptoms in 22q11.2DS. Our findings indicated that ADHD symptoms, particularly 
inattentive, were associated with subthreshold psychosis in 22q11.2DS. ADHD 
inattention symptoms were present at higher rates in 22q11.2DS, compared to ND 
individuals with subthreshold psychosis and ND individuals with family history of 
psychosis, further supporting a potentially important role of ADHD inattention symptoms 
in psychosis in 22q11.2DS. Our results also highlight the significance of employing a 
dimensional approach in addition to diagnostic categories. Further longitudinal studies 
are needed to replicate our findings as a potentially causal role of ADHD inattention 
symptoms in psychosis in 22q11.2DS can have important implications for prevention 
and treatment of psychosis in 22q11.2DS as well as beyond this syndrome.   
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1Supplemental material 
STable 1. Supplementary analysis examining only Caucasians: Comparisons of ADHD symptomatology between individuals with 
22q11.2DS and subthreshold psychosis and individuals without the deletion with subthreshold psychosis. 
Variable 22q11.2DS and 
subthreshold 
psychosis (n=62)
ND subthreshold 
psychosis (n=27)
Mean(SD)/range Mean(SD)/range χ2, z P
Age 14.1(4.1)/8-23 16.5(2.8)/11-22 8.21 0.004
WRAT4 42.7(10.6)/19-60 52.2(8.3)/27-63 3.81 p<0.001
Executive -0.63(1.04)/-3.5-0.59 0.65(0.7)/-1.2-1.6 4.15 p<0.001
N(%) N(%) χ2 P
Gender (males)(%) 34(55) 17(63) 0.51 0.48
ADHD diagnosis 32(52) 8(30) 3.67 0.06
Mean(SD) Mean(SD) z P
ADHD inattention 
symptoms
5.9(2.9) 4.1(3.0) -2.59 0.01
ADHD hyperactivity-
impulsivity symptoms
3.2(2.7) 2.5(2.4) -0.87 0.39
ADHD total symptoms 8.5(4.8) 6.5(4.5) -1.73 0.08
Abbreviations: ND: individuals without the deletion, ADHD-Attention Deficit Hyperactivity 
Disorder, WRAT4- Wide Range Achievement Test 4.
2STable 2. Supplementary analysis examining only Caucasians: Comparisons of ADHD symptomatology between individuals with 
22q11.2DS and individuals without the deletion with family history of psychosis.  
Variable 22q11.2DS (n=118) Family history of 
psychosis (n=9)
Mean(SD)/range Mean(SD)/range χ2, z p
Age 14.1(4.5)/8-24 16.0(1.6)/14-19 2.46 p<0.001
WRAT4 42.5(11.2)/16-62 53.3(5.7)/48-60 1.90 0.06
Executive -0.66(1.1)/-3.5-0.9 0.89(0.3)/0.6-1.2 3.09 0.002
N(%) N(%) χ2 p
Gender (males)(%) 62(53) 5(56) 0.03 0.86
Diagnosis Schizophrenia 3(3) 0(0) 0.24 0.62
Psychosis 4(4) 0(0) 0.32 0.57
Subthreshold 
psychosis
62(54) 4(44) 0.30 0.58
ADHD 53(46) 1(11) 4.15 0.04
Mean(SD) Mean(SD) Z p
ADHD inattention symptoms 5.28(3.3) 2.67(3.5) -2.23 0.03
ADHD hyperactivity- impulsivity
symptoms
2.75(2.7) 0.63(1.4) -2.30 0.02
ADHD total symptoms 7.59(5.0) 3.22(4.1) -2.40 0.02
Abbreviations: ADHD-Attention Deficit Hyperactivity Disorder, WRAT4- Wide Range 
Achievement Test 4.
3STable 3. Matched age and gender comparisons of ADHD symptomatology between individuals with 22q11.2DS and individuals 
without the deletion with family history of psychosis.
Variable 22q11.2DS (n=31) Family history of 
psychosis (n=31)
Mean(SD)/range χ2, z p
Age 17.0(2.3)/11-23
WRAT 0.19(0.2)/-1.7-1.4 0.5(0.5)/-1.0-1.8 1.8 0.07
Executive -0.27(0.4)/-0.7-0.6 0.8(0.4)/-0.1-1.4 2.02 0.04
N(%)
Gender (males)(%) 14 (4) χ2 p
ADHD diagnosis(%) 13(42) 3(10) 0.8 0.36
Mean(SD) Mean(SD) z p
ADHD inattention 
symptoms
5.4(3.5) 2.7(2.8) -2.5 0.01
ADHD hyperactivity -
impulsivity symptoms
1.9(2.5) 1.2(2.0) -0.4 0.68
ADHD total symptoms 7.0(4.6) 3.9(4.0) -2.2 0.03
Abbreviations: ADHD-Attention Deficit Hyperactivity Disorder, WRAT4- Wide Range 
Achievement Test 4.
Table 1. The relationship between ADHD symptoms, SOPS symptoms, and psychosis in individuals with 22q11.2DS. 
ADHD inattention symptoms ADHD hyperactivity- impulsivity symptoms ADHD total symptoms
Coefficient(95%CI) Cohen’s f2 p Coefficient(95%CI) Cohen’s f2 p Coefficient(95%CI) Cohen’s f2 p
SOPS symptoms
Positive 0.52(0.17-0.86) 0.07 0.004 0.10(-0.33-0.54) 0.00 0.64 0.19(-0.03-0.41) 0.02 0.09
Negative 0.49(0.06-0.93) 0.04 0.03 0.08(-0.48-0.64) 0.00 0.78 0.16(-0.11-0.44) 0.01 0.24
Disorganized 0.52(0.24-0.81) 0.11 p<0.001 0.48(0.11-0.85) 0.06 0.01 0.32(0.14-0.50) 0.10 p<0.001
General 0.21(-0.13-0.55) 0.01 0.22 0.30(-0.13-0.73) 0.02 0.17 0.15(-0.07-0.36) 0.02 0.18
Total SOPS 1.74(0.49-2.99) 0.06 0.01 0.96(-0.65-2.58) 0.01 0.24 0.82(0.02-1.61) 0.04 0.04
Diagnoses Odds ratio (95%CI) p Odds ratio (95%CI) p Odds ratio (95%CI) p
Subthreshold 
psychosis
1.18(1.05-1.31) 0.004 1.21(1.04-1.40) 0.01 1.12(1.04-1.20) 0.003
Schizophrenia 1.47(0.83-2.60) 0.182 1.10(0.73-1.66) 0.66 1.12(0.90-1.39) 0.31
Psychosis Diagnosis 1.05(0.81-1.38) 0.71 0.92(0.65-1.30) 0.63 1.00(0.85-1.17) 0.98
Abbreviations: SOPS= Scale of Prodromal Symptoms, ADHD=Attention Deficit Hyperactivity Disorder
Notes: Linear regression analyses where SOPS symptoms/Diagnoses are the outcome variable and ADHD symptoms are the predictor variable. Psychosis Diagnosis = all 
non-schizophrenia psychotic disorders and mood disorders with psychotic features.
Table 2. Comparisons of ADHD symptomatology between individuals with 22q11.2DS and subthreshold psychosis and individuals without the 
deletion with subthreshold psychosis. 
Variable 22q11.2DS PS+ (n=72) ND PS+ (n=84)
Mean(SD)/range Mean(SD)/range χ2, z p Cohen’s d
Age 13.9(4.1)/8 to 23 16.9(2.7)/11-23 -24.2 <0.001 -0.88
WRAT4 -0.4(1.0)/-2.5-1.2 1.3(0.8)/-1.9-1.8 -4.2 <0.001 -1.89
Executive -0.8(1.1)/-3.5-0.6 0.5(0.7)/-2.0-2.1 -5.1 <0.001 -1.43
Mean(SD) Mean(SD) χ2, z p Cohen’s d
Estimated household income ($) 69644(27611) 48631(27655) 32.6 <0.001 0.76
Maternal education level 15.0(2.3) 14.4(2.4) 3.5 0.06 0.26
N(%) N(%) χ2 p
Gender (males)(%) 40(56) 40(48) 0.98 0.32 0.16
Race: Caucasian 62(86) 27(32)
African-American 4(6) 46(55)
Mixed 2(3) 0(0)
Asian 4(5) 11(13) 53.71 <0.001 -0.77
ADHD diagnosis 41(57) 16(19) 25.0 <0.001 0.87
SOPS symptoms
Positive 6.5(4.6) 8.5(4.6) -2.7 0.01 -0.43
Negative 11.0(4.6) 8.3(5.5) 3.3 0.001 0.53
Disorganized 5.5(3.1) 4.0(3.0) 3.0 0.003 0.49
General 6.8(4.6) 3.7(2.9) 4.9 <0.001 0.82
Total SOPS 29.9(11.6) 24.5(9.9) 3.0 0.003 0.50
Mean(SD) Mean(SD) z p z* p* z** p** z*** p***
ADHD inattention symptoms 6.1(2.9) 3.4(2.8) 5.4 <0.001 0.95 4.8 <0.001 4.2 <0.001 3.3 0.001
ADHD hyperactivity- impulsivity 
symptoms
3.6(2.8) 2.2(2.4) 2.9 0.004 0.54 1.7 0.10 0.2 0.87 0.7 0.50
ADHD total symptoms 9.1(4.8) 5.6(4.6) 4.3 <0.001 0.75 3.7 <0.001 2.3 0.02 2.0 0.05
Abbreviations: 22q PS+= 22q11.2 DS and subthreshold psychosis, ND PS+= Non-deleted subthreshold psychosis, ADHD-Attention Deficit Hyperactivity Disorder, WRAT4-
Wide Range Achievement Test 4, SOPS= Scale of Prodromal Symptoms. 
Notes: Statistically significant variables are highlighted in bold. *regressing out WRAT4 and age **regressing out age, WRAT4 and executive ***regressing out age, WRAT4, 
executive and total SOPS (excluding item D3 – significant attentional impairments). 
Table 3. Comparisons of ADHD symptomatology between individuals with 22q11.2DS and individuals without the deletion with family history 
of psychosis.  
Variable 22q11.2DS (n=137) Family history of psychosis (n=31)
Mean(SD)/range Mean(SD)/range χ2, z p Cohen’s d
Age 14.0(4.5)/8 to 23 17.0(2.3)/11-23 -13.8 <0.001 -0.72
WRAT4 -0.36(1.0)/-2.6-1.4 0.50(0.8)/-1.0-1.8 -3.2 0.002 -0.89
Executive -0.75(1.1)/-3.5-0.9 0.75(0.4)/-0.1-1.4 -5.2 <0.001 -1.49
Mean(SD) Mean(SD) χ2, z p Cohen’s d
Estimated household income ($) 70617(29710) 41032(20449) 32.5 <0.001 1.05
Maternal education level 15.0(2.4) 13.3(2.3) 12.5 <0.001 0.71
N(%) N(%) χ2 p
Gender (males)(%) 72(53) 14(45) 0.6 0.50 0.12
Race Caucasian 118(86) 9(29)
African-American 12(9) 18(58)
Mixed 2(2) 0(0)
Asian 5(3) 4(13) 49.8 <0.001 -1.12
ADHD diagnosis 65(49) 3(10) 15.7 <0.001 0.64
Mean(SD) Mean(SD)
SOPS Positive 5.7(6.3) 7.9(6.3) -2.0 0.04 -0.35
Negative 9.5(7.8) 6.4(6.4) 2.8 0.005 0.41
Disorganized 5.2(5.3) 3.7(3.8) 1.8 0.07 0.30
General 6.1(6.0) 3.4(3.6) 2.9 0.004 0.48
Total 26.5(22.7) 21.4(16.5) 1.22 0.22 0.24
Mean(SD) Mean(SD) z p z* p* z** p** z*** p***
ADHD inattention symptoms 5.4(3.2) 2.7(2.8) 4.1 <0.001 0.86 4.8 <0.001 4.18 <0.001 2.34 0.02
ADHD hyperactivity -impulsivity 
symptoms
3.0(2.8) 1.2(1.9) 3.3 <0.001 0.68 1.7 0.10 0.17 0.87 1.23 0.22
ADHD total symptoms 7.9(5.1) 3.9(4.0) 4.0 <0.001 0.81 3.7 <0.001 2.31 0.02 2.03 0.04
Abbreviations: ADHD-Attention Deficit Hyperactivity Disorder, WRAT4- Wide Range Achievement Test 4.*regressing out WRAT4 and age **regressing out age, WRAT4 
and executive ***regressing out age, WRAT4, executive and total SOPS(excluding item D3 – significant attentional impairments). Psychosis = all non-schizophrenia 
psychotic disorders and mood disorders with psychotic features.
